No abstract available
Keywords:
Maintenance therapy; Ovarian neoplasms; Poly(ADP-ribose) polymerase inhibitors.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Angiogenesis Inhibitors / pharmacology
-
Angiogenesis Inhibitors / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / pharmacology
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Biomarkers, Tumor / genetics*
-
Chemotherapy, Adjuvant / methods
-
Clinical Decision-Making
-
Clinical Trials as Topic
-
Cytoreduction Surgical Procedures
-
Evidence-Based Medicine / methods
-
Female
-
Humans
-
Maintenance Chemotherapy / methods
-
Neoadjuvant Therapy / methods*
-
Neoplasm Staging
-
Ovarian Neoplasms / diagnosis
-
Ovarian Neoplasms / genetics
-
Ovarian Neoplasms / mortality
-
Ovarian Neoplasms / therapy*
-
Ovariectomy
-
Poly(ADP-ribose) Polymerase Inhibitors / pharmacology
-
Poly(ADP-ribose) Polymerase Inhibitors / therapeutic use
-
Practice Guidelines as Topic
-
Precision Medicine / methods
-
Progression-Free Survival
Substances
-
Angiogenesis Inhibitors
-
Biomarkers, Tumor
-
Poly(ADP-ribose) Polymerase Inhibitors